Inspecs Group PLC
LSE:SPEC
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
47
92
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Inspecs Group PLC
Inspecs Group PLC
Cash from Financing Activities
Inspecs Group PLC
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Inspecs Group PLC
LSE:SPEC
|
Cash from Financing Activities
-£8.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Abingdon Health PLC
LSE:ABDX
|
Cash from Financing Activities
-£7k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ConvaTec Group PLC
LSE:CTEC
|
Cash from Financing Activities
-$124m
|
CAGR 3-Years
9%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Tristel PLC
LSE:TSTL
|
Cash from Financing Activities
-£5.6m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-33%
|
|
|
Advanced Medical Solutions Group PLC
LSE:AMS
|
Cash from Financing Activities
£65.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cambridge Nutritional Sciences PLC
LSE:CNSL
|
Cash from Financing Activities
-£265k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Inspecs Group PLC
Glance View
Inspecs Group Plc engages in designing, production, selling, marketing, and distribution of fashion eyewear, lenses and OEM products worldwide. The company is headquartered in Bath, Somerset and currently employs 1,800 full-time employees. The company went IPO on 2020-02-27. The firm is a designer, manufacturer and distributor of eyewear frames and optical spectacle lenses. The firm produces a range of frames and lenses, covering optical, sunglasses and safety. The company has operations across the globe, including the United Kingdom, Portugal, Scandinavia, the United States and China (Hong Kong, Macau and Shenzhen), and manufacturing facilities in Vietnam, China, the United Kingdom and Italy. The firm also operates across Europe and the American markets. Its customers include global optical and non-optical retailers, global distributors and independent opticians, with its distribution network covering over 80 countries and reaching approximately 70,000 points of sale.
See Also
What is Inspecs Group PLC's Cash from Financing Activities?
Cash from Financing Activities
-8.8m
GBP
Based on the financial report for Dec 31, 2023, Inspecs Group PLC's Cash from Financing Activities amounts to -8.8m GBP.
What is Inspecs Group PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-20%
Over the last year, the Cash from Financing Activities growth was -149%.
You don't have any saved screeners yet
